Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2021-04-19 Investor Presentation
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Intimation of Schedule of Analysts / Institutional Investors meeting over conference call under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 Pursuant ....
Investor Presentation Classification · 90% confidence The document is a short notice informing the stock exchange about a scheduled conference call with analysts and institutional investors. It references a future interaction to discuss an investor presentation but does not contain the presentation itself or any financial data. The document is an announcement of a meeting schedule under SEBI regulations, not the actual investor presentation or financial report. Given the length (1843 characters) and content, it fits the category of an Investor Presentation announcement or meeting notice. However, since it is only an intimation of the schedule of the call and not the presentation itself, the best fitting category is 'Investor Presentation' (IP) as it relates to investor communication about financials and strategy, even though the presentation is not attached here. Confidence is high due to clear mention of analyst/institutional investor meeting and reference to investor presentation discussion.
2021-04-19 English
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, Company''s Code of Conduct for Prevention of Insider Trading, and BSE circular no. LIST/COMP/01/2019-20 ....
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window pursuant to SEBI regulations and company code of conduct. It informs about the trading restrictions around the period of financial results announcement but does not contain any financial data, results, or detailed report. The document is short (2742 characters) and serves as an announcement related to insider trading restrictions rather than a financial report or earnings release. Therefore, it does not fit into categories like Earnings Release (ER) or Interim Report (IR). It is also not a certification or legal proceeding. The best fitting category is Regulatory Filings (RNS), which is a fallback for miscellaneous regulatory announcements that do not fit other categories.
2021-03-26 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from Link Intime India ....
Regulatory Filings Classification · 100% confidence The document is an intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificates. It is addressed to the stock exchange and provides details about the stop transfer of shares due to lost certificates. The document is a regulatory announcement informing the exchange and public about a specific event related to share certificates. It does not contain financial statements, management discussion, or any report content. It is not a report itself but a regulatory filing notifying about a corporate event related to share certificates. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is short and it is a formal notification, not a report or announcement of a report publication.
2021-03-12 English
Intimation of Schedule of Analysts / Institutional Investors meeting under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 Pursuant to the relevant provisions ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about the schedule of an upcoming investor meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and explicitly states that no unpublished price sensitive information will be discussed. The document is brief (1815 characters) and serves as an announcement rather than a detailed report or transcript. It does not contain financial data, management discussion, or detailed presentation content. Therefore, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement category for miscellaneous filings that do not fit other specific categories.
2021-03-02 English
Transcript of Schedule of Analysts / Institutional Investors meeting held on February 15, 2021 regarding the financial performance of the Company for the quarter ended December 31, 2020 ....
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on February 15, 2021, discussing the financial performance of Fermenta Biotech Limited for the quarter ended December 31, 2020. It includes detailed management commentary on financial results, business developments, acquisitions, and Q&A with analysts. The presence of a moderator, management speakers, and Q&A session confirms this is a full earnings call transcript. The document is about 15,000 characters long, contains substantive financial data and analysis, and is not merely an announcement or summary. Therefore, it fits the definition of a Call Transcript (CT).
2021-02-20 English
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide ....
Regulatory Filings
2021-02-15 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.